CHRS

NASDAQStock

Coherus Oncology, Inc.

$1.63-0.07 (-3.85%)

52-Week Range

$0.72
$2.51

Key Stats

Market Cap

196.4M

P/E Ratio

1.19

Dividend Yield

Beta

1.09

Volume

989.8K

Avg Volume

1.4M

Performance

1M

+4.97%

3M

+21.58%

6M

+24.26%

YTD

+23.36%

1Y

+84.56%

3Y

-73.47%

5Y

-89.42%

Price Chart

ETF Exposure

CHRS is held by 51 ETFs

ETFFund NameWeight
SURISimplify Propel Opportunities ETF0.85%
QQQSInvesco NASDAQ Future Gen 200 ETF0.63%
SAGPStrategas Global Policy Opportunities ETF0.25%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.19%
DMRSDeltaShares S&P 600 Managed Risk ETF0.11%
STSBiShares Factors US Small Blend Style ETF0.10%
SLYSPDR S&P 600 Small Cap ETF0.04%
IWCiShares Micro-Cap ETF0.04%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.02%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.02%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.02%
IBBQInvesco Nasdaq Biotechnology ETF0.02%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
VTWVVanguard Russell 2000 Value ETF0.01%
IWNiShares Russell 2000 Value ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
IWMiShares Russell 2000 ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
IWOiShares Russell 2000 Growth ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
VTWGVanguard Russell 2000 Growth ETF0.01%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.01%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.01%
URTYProShares - UltraPro Russell20000.00%
UWMProShares - Ultra Russell20000.00%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
VXFVanguard Extended Market ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
Page 1 of 2Next

About CHRS ETF Exposure

Coherus Oncology, Inc. (CHRS) is held by 51 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 196.4M, CHRS is a widely held institutional stock. The stock currently trades at $1.63. Investors can gain exposure to CHRS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CHRS, sorted by portfolio weight.